Share

Xarelto

Xarelto, an anticoagulant that was approved by the US Food and Drug Administration (FDA) in 2011, has been linked to an increased risk of uncontrollable bleeding (hemorrhaging).

What is Xarelto?

Xarelto (known generically as Rivaroxaban) is a new-generation anticoagulant, in a class of drugs known as direct thrombin inhibitors. It is a blood thinner used to reduce the risk of blood clots and strokes.

What You Should Know

Xarelto has reportedly been linked to an increased risk of uncontrollable bleeding (hemorrhaging). A risk of hemorrhaging exists in many blood thinners; however, warfarin has an antidote that can reduce the risk of uncontrollable hemorrhaging. Some newer blood thinners, including Xarelto, do not have such an antidote. This means that injuries—including minor cuts or internal bleeding—can result in uncontrolled bleeding, which can be fatal.

Injuries Resulting from Use of Xarelto

• Stroke
• Retinal hemorrhages
• Epidural hematoma
• Intracranial hemorrhages
• Pulmonary embolism
• Hemoglobin decrease
• Gastrointestinal hemorrhages
• Deep vein thrombosis
• Adrenal bleeding
• Death

Xarelto Lawsuit Evaluation: If you or a loved one suffered a bleeding episode after using Xarelto, you should contact The Falkowitz Law Firm immediately. You may be entitled to compensation by filing a Xarelto lawsuit and we can help.



© 2017 Falkowitz Law Firm, PLLC | Disclaimer
1225 Franklin Avenue, Suite 325, Garden City, NY 11530
| Phone: 888-222-3255 | 516-570-5000

Practice Areas | For Lawyers | FAQs

Law Firm Website Design by
Zola Creative


© 2015 Falkowitz Law Firm, PLLC | Disclaimer
1225 Franklin Avenue, Suite 325, Garden City, NY 11530

888-222-FALK | 888-222-3255 | 516-570-5000

For Lawyers | Practice Areas

Law Firm Website Design by
Amicus Creative